Positive Updated Results from MajesTEC-1 Study in Relapsed/Refractory Multiple Myeloma
![Positive Updated Results from MajesTEC-1 Study in Relapsed/Refractory Multiple Myeloma](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_480/images.spreaker.com/original/94bbcd9383e135a83910351743c22620.jpg)
Iscriviti gratuitamente
Ascolta questo episodio e molti altri. Goditi i migliori podcast su Spreaker!
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
Ajay K. Nooka, MD, Associate Professor of Hematology and Medical Oncology at Emory School of Medicine, discusses the updated efficacy and safety results from the phase 1/2 MajesTEC-1 study evaluating...
mostra di piùMultiple myeloma is a rare blood cancer associated with uncontrolled growth of plasma cells. Abnormal plasma cells – also known as myeloma cells – interfere with the production of healthy blood cells in the bone marrow. Symptoms of multiple myeloma may include: bone pain (particularly in the chest and spine), frequent infections, weakness or numbness in the legs, fatigue, confusion, excessive thirst, and constipation. While the disease is treatable, relapses are common and some patients are refractory to first line, and subsequent, therapies.
Informazioni
Autore | Peter Ciszewski, CheckRare |
Sito | - |
Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company